GR1007341B - Διαγνωστικος προσδιορισμος - Google Patents

Διαγνωστικος προσδιορισμος

Info

Publication number
GR1007341B
GR1007341B GR20100100240A GR20100100240A GR1007341B GR 1007341 B GR1007341 B GR 1007341B GR 20100100240 A GR20100100240 A GR 20100100240A GR 20100100240 A GR20100100240 A GR 20100100240A GR 1007341 B GR1007341 B GR 1007341B
Authority
GR
Greece
Prior art keywords
target molecule
binding
molecules
sample
biological sample
Prior art date
Application number
GR20100100240A
Other languages
English (en)
Inventor
Σωκρατης Ιωαννη Τζαρτος
Νικολαος Τρακας
Ιωαννης Τζαρτος
Χρηστος Στεργιου
Παρασκευη Ζησιμοπουλου
Original Assignee
ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ (κατά ποσοστό 40%),
ΣΩΚΡΑΤΗΣ (κατά ποσοστό 24%), ΤΖΑΡΤΟΣ
ΙΩΑΝΝΗΣ (κατά ποσοστό 18%), ΤΖΑΡΤΟΣ
ΕΛΙΣΣΑΒΕΤ (κατά ποσοστό 18%), ΤΖΑΡΤΟΥ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ (κατά ποσοστό 40%),, ΣΩΚΡΑΤΗΣ (κατά ποσοστό 24%), ΤΖΑΡΤΟΣ, ΙΩΑΝΝΗΣ (κατά ποσοστό 18%), ΤΖΑΡΤΟΣ, ΕΛΙΣΣΑΒΕΤ (κατά ποσοστό 18%), ΤΖΑΡΤΟΥ filed Critical ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ (κατά ποσοστό 40%),
Priority to GR20100100240A priority Critical patent/GR1007341B/el
Priority to EP11724450A priority patent/EP2561358A2/en
Priority to PCT/IB2011/001014 priority patent/WO2011132077A2/en
Publication of GR1007341B publication Critical patent/GR1007341B/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Μέθοδος για την ανίχνευση της παρουσίας ενός μορίου-στόχου σε ένα βιολογικό δείγμα από ένα άτομο, όπου το μόριο στόχος είναι ικανό να συνδέεται με ένα μόριο δεσμεύσεως, όπου η μέθοδος περιλαμβάνει τα στάδια: a) της υποβολής του βιολογικού δείγματος σε ένα στάδιο καθαρισμού για την παροχή ενός εμπλουτισμένου σε μόριο στόχο δείγματος, όπου το στάδιο καθαρισμού περιλαμβάνει: i) την επαφή του βιολογικού δείγματος με μόρια δεσμεύσεως για να επιτραπεί η σύνδεση των μορίων στόχων με τα μόρια δεσμεύσεως, και ii) την απομάκρυνση των μορίων στόχων από τα μόρια δεσμεύσεως για την παροχή του εμπλουτισμένου δείγματος μορίων στόχων- και b) της υποβολής του εμπλουτισμένου δείγματος μορίων στόχων σε μια δοκιμασία για την ανίχνευση της παρουσίας του μορίου στόχου.
GR20100100240A 2010-04-21 2010-04-21 Διαγνωστικος προσδιορισμος GR1007341B (el)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GR20100100240A GR1007341B (el) 2010-04-21 2010-04-21 Διαγνωστικος προσδιορισμος
EP11724450A EP2561358A2 (en) 2010-04-21 2011-04-18 Diagnostic assay
PCT/IB2011/001014 WO2011132077A2 (en) 2010-04-21 2011-04-18 Diagnostic assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20100100240A GR1007341B (el) 2010-04-21 2010-04-21 Διαγνωστικος προσδιορισμος

Publications (1)

Publication Number Publication Date
GR1007341B true GR1007341B (el) 2011-07-05

Family

ID=44510129

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20100100240A GR1007341B (el) 2010-04-21 2010-04-21 Διαγνωστικος προσδιορισμος

Country Status (3)

Country Link
EP (1) EP2561358A2 (el)
GR (1) GR1007341B (el)
WO (1) WO2011132077A2 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011011280A1 (de) * 2011-02-15 2012-08-16 Euroimmun Medizinische Labordiagnostika Ag Diagnosekit sowie ein Verfahren zur Untersuchung einer menschlichen Patientenprobe auf das Vorhandensein von Neuromyelitis-optica-spezifischen Antikörpern
DE102014226663A1 (de) * 2014-12-19 2016-06-23 Charité Universitätsmedizin Berlin Brückenassays zum Nachweis von Antikörpern gegen Mitglieder der kardialen Rezeptorfamilie
US11155575B2 (en) 2018-03-21 2021-10-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbent, devices and methods
CN114487448B (zh) * 2022-01-21 2022-10-18 天津天海新域生物科技有限公司 用于检测重症肌无力相关抗体的组合物、试剂盒及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033722A (en) 1975-08-08 1977-07-05 The Salk Institute For Biological Studies Assay for myasthenia gravis
US4789640A (en) * 1986-01-06 1988-12-06 The Salk Institute For Biological Studies Assays for myasthenia gravis
GB0014878D0 (en) 2000-06-16 2000-08-09 Isis Innovation Neurotransmission disorders
US7101679B2 (en) 2003-11-25 2006-09-05 Mayo Foundation For Medical Education And Research Marker for neuromyelitis optica

Also Published As

Publication number Publication date
WO2011132077A3 (en) 2012-05-18
EP2561358A2 (en) 2013-02-27
WO2011132077A2 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
WO2013157917A3 (en) A biosensor and preparation method thereof
EP2576833A4 (en) METHOD AND DEVICE FOR THE POINT-OF-CARE DETECTION OF NUCLEIC ACID IN A SAMPLE
CL2011002228A1 (es) Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas.
WO2011116006A3 (en) A rapid method to measure cyanide in biological samples
WO2013050881A3 (en) Direct nucleic acid analysis
WO2014028378A3 (en) Methods and systems for detecting biological components
WO2013040435A3 (en) Molecular diagnostic assay device and method of use
WO2005103298A3 (en) Method for detecting ncrna
WO2011022093A3 (en) Methods and devices for detecting the presence of an analyte in a sample
WO2012162165A3 (en) Antibodies to 25-hydroxyvitamin d2 and d3 and uses thereof
AU2012262364A8 (en) Systems and methods for genetic and biological analysis
WO2011100708A3 (en) Assay card for sample acquisition, treatment and reaction
WO2011136624A3 (ko) 자기장 인가부를 구비한 생물학적 시료 자동정제장치, 생물학적 시료로부터 타겟물질을 추출하는 방법, 그리고 단백질 발현 및 정제 방법
WO2009060847A1 (ja) 核酸増幅用サンプルの調製方法及び調製キット
EA201291396A1 (ru) Способ детекции молекулярных взаимодействий
WO2011121454A3 (en) Direct nucleic acid analysis
EP2254897A4 (en) METHOD, REAGENTS AND KITS FOR DETECTING NUCLEIC ACID MOLECULES
MX2014006118A (es) Deteccion de analitos.
BR112012024206A2 (pt) método e sistema para analisar uma amostra de sangue
BRPI0916111A2 (pt) cubeta para armazenar uma amostra biol[ogica a ser analisada por meio de uma técnica de detecção pré definida, método para a fabricação de uma cubeta, método para autenticar uma cubeta, método para analisar uma amostra biológica e sistema para analisar uma amostra biológica
WO2009126848A3 (en) Analyzing large data sets using a computer system
EP2504348A4 (en) METHODS, REAGENTS AND KITS FOR DETECTING NUCLEIC ACID MOLECULES
WO2009034842A1 (ja) 核酸検出方法、および核酸検出キット
GB201206977D0 (en) An enzyme detection device
WO2012103260A3 (en) High-throughput methods to produce, validate and characterize mmabs

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20110829